Generics to improve access to life-saving drug

Semaglutide isn't just a buzzword: It helps people manage type 2 diabetes and supports weight loss by controlling blood sugar and appetite.
With generics entering the market, prices could drop to as low as ₹1,500 to ₹2,500 per month over time. This means better access for many who need it.

Pharma giants and hospitals gear up for the change

Pharma giants like Zydus and Lupin are teaming up to get ready for demand spikes. Hospitals are even rolling out new obesity programs in anticipation.
Still, doctors' trust will play a big role: Brands that don't measure up will likely exit within two to three years as patients stick with what works best.